Skip to main content
BTMD
NASDAQ Life Sciences

Q3 Revenue Falls 9.6% as Biote's Turnaround Stalls; Guidance Held

Tom Rudovsky · Reported by BusinessWire
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$1.23
Mkt Cap
$44.191M
52W Low
$1
52W High
$2.98
52W Position info
23% above low
Off High info
59% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

BTMD sits 23% above its 52-week low of $1.

Summary

Revenue dropped 9.6% to $43.3 million and procedure revenue fell 15.1% to $28.9 million, with interim CEO Bob Peterson conceding the return to growth is 'progressing more slowly than anticipated.' Adjusted EBITDA collapsed to $5.1 million from $12.9 million a year ago, and gross margin slipped to 67.7% from 71.8% on continued use of lower-margin third-party pellets after the January 2026 recall. Net income was just $0.6 million, or $0.01 per diluted share, versus $9.2 million and $0.22 a year earlier. Cash fell to $8.9 million from $24.1 million at year-end, a thin cushion against a $117 million term loan. Management kept full-year 2026 guidance unchanged at revenue above $175 million and adjusted EBITDA above $25 million, which now looks stretched given the nine-month revenue run rate of $132.5 million.

At the time of this announcement, BTMD was trading at $1.23 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $44.2M. The 52-week trading range was $1.00 to $2.98. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

BTMD - Latest Insights

BTMD
Nov 09, 2026, 5:07 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.11
Real-time Price: $0.8105 info
Change: -$0.2995 (-27%) info
Market Cap: $45.352M info
BTMD
Aug 12, 2026, 4:25 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $1.55
Real-time Price: $0.8105 info
Change: -$0.7395 (-48%) info
Market Cap: $45.352M info
BTMD
Aug 07, 2026, 4:30 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.53
Real-time Price: $0.8105 info
Change: -$0.7149 (-47%) info
Market Cap: $45.352M info
BTMD
Aug 05, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.97
Real-time Price: $0.8105 info
Change: -$1.16 (-59%) info
Market Cap: $45.352M info
BTMD
Jun 17, 2026, 4:05 PM EDT
Filing Type: 8-K/A
Importance Score:
7
Price at Filing: $2.27
Real-time Price: $0.8105 info
Change: -$1.46 (-64%) info
Market Cap: $45.352M info